安心交易
不成功退款,无后顾之忧,风险服务升级。5大免费服务
1.提供最新期刊信息 2.提供最全期刊目录 3.提供投稿格式模板 4.协助查询文献 5.免费推荐期刊
Molecular TherapyMolecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide-, protein-, oligonucleotide-, and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Molecular Therapy is dedicated to promoting the sciences in genetics, medicine, and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy''s 2015 impact factor is 6.938.Molecular Therapy — OncolyticsMolecular Therapy—Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or transfer of cells and/or genes. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy—Oncolytics will build upon the success of Molecular Therapy and its sibling journals in publishing important peer-reviewed original research and editorial commentary.
分子治疗《分子疗法》杂志是基因转移、载体开发与设计、干细胞操作、基因、肽、蛋白、寡核苷酸的开发、细胞疗法、疫苗开发、临床前目标验证、安全性/有效性研究和临床试验等领域的领先期刊。分子疗法致力于促进遗传学、医学和生物技术的科学发展。出版重要的同行评审研究和前沿评论和评论,该杂志继续吸引该领域的最佳材料。分子治疗2015年影响因子为6.938。分子疗法-溶瘤疗法《分子治疗- oncolytics》是一本国际性的、在线的、开放获取的杂志,专注于针对癌症的病毒、细胞和其他生物疗法的开发和临床测试。同时提供一个独特的论坛在新兴领域的溶瘤病毒治疗工作,以及T细胞,干细胞疗法,《华尔街日报》将考虑所有优质,尖端研究,采用创新的分子和细胞的方法,目标肿瘤细胞破坏,是否由病毒、其他微生物,免疫接种,或转移的细胞和/或基因。作为美国基因与细胞治疗学会的官方期刊,分子治疗-溶瘤学将建立在分子治疗及其兄弟期刊的成功基础上,发表重要的同行评审的原始研究和编辑评论。
| 大类学科 | 分区 | 小类学科 | 分区 | Top期刊 | 综述期刊 |
| 医学 | 2区 | MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验 ONCOLOGY 肿瘤学 | 2区 2区 | 否 | 否 |
| JCR分区等级 | JCR所属学科 | 分区 | 影响因子 |
| Q2 | ONCOLOGY | Q2 | 6.311 |
| MEDICINE, RESEARCH & EXPERIMENTAL | Q2 |
安心交易
不成功退款,无后顾之忧,风险服务升级。
合规备案认证机构
资质许可齐全,合规经营,用户权益有保障。
正刊保障
刊物在国家新闻出版署网可查,抵制假刊、增刊。
对公账户资金监管
交易均通过对公账户,资金安全有保障。